ORF Genetics specialises in plant biotechnology that creates high-quality recombinant proteins, including human and animal growth factors, using bioengineered barley.
ORF Genetics has raised €5.0M across 1 funding round, most recently a round in Sep 2025. Based in Kópavogur, Iceland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-11 | Other | €5.0M |
| — |
| View deal → |
